The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, D.
Right arrow Articles by Shi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, D.
Right arrow Articles by Shi, Y.
The Journal of Immunology, 1999, 163: 4328-4334.
Copyright © 1999 by The American Association of Immunologists

Ligation of CD28 In Vivo Induces CD40 Ligand Expression and Promotes B Cell Survival1

Deling Yin*, Liying Zhang*, Ruoxiang Wang*, Laszlo Radvanyi2, Christian Haudenschild{dagger}, Qiding Fang*, Marilyn R. Kehry{ddagger} and Yufang Shi3,*

Departments of * Immunology and {dagger} Experimental Pathology, Jerome H. Holland Laboratory, American Red Cross, Rockville, MD 20855; {ddagger} Department of Biology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877; and § Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada

Functional activation of T cells requires ligation of Ag receptors with specific peptides presented by MHC molecules on APCs concurrent with appropriate contacts of cell surface accessory molecules. Among these accessory molecules, interactions between CD28/CTLA-4 with B7 family members (CD80 and CD86) and CD40 with CD40 ligand (CD40L) play a decisive role in regulating the progression of balanced immune responses. However, most information regarding the role of accessory molecules in immune responses has been derived in the context of signals from the TCRs. Little understanding has been achieved regarding the consequence of ligation of costimulation molecules in absence of signals from the TCR. By employing an in vivo murine system, we show, herein, that ligation of CD28 alone with anti-CD28 Abs leads to a dramatic enlargement of the peripheral lymphoid organs characterized primarily by the expansion of B cells. B cells from anti-CD28-treated mice are resistant to spontaneous and anti-IgM-induced apoptosis. These cells are also unsusceptible to FasL-mediated apoptosis. Interestingly, this in vivo effect of CD28 on B cells is largely mediated by inducing the expression of CD40L, since coadministration of a blocking Ab against CD40L inhibited CD28-mediated B cell survival and expansion. Therefore, CD28-mediated expression of CD40L may play an important role in the regulation of lymphocyte homeostasis.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. M. L. Tamma, K. W. Chung, T. Patel, S. P. Balan, and S. Pahwa
p38 MAPK plays a role in IL-4 synthesis in jacalin plus CD28-stimulated CD4+ T cells--II
J. Leukoc. Biol., June 1, 2006; 79(6): 1339 - 1347.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. L. Tamma, S. P. Balan, K. W. Chung, and S. Pahwa
The lectin jacalin plus costimulation with anti-CD28 antibody induces phosphorylation of p38 MAPK and IL-4 synthesis-I
J. Leukoc. Biol., April 1, 2006; 79(4): 876 - 880.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. E. Feldon, D. J. J. Park, C. W. O'Loughlin, V. T. Nguyen, S. Landskroner-Eiger, D. Chang, T. H. Thatcher, and R. P. Phipps
Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves' Ophthalmopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3913 - 3921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Pollard, M. Arnush, P. Hultman, and D. H. Kono
Costimulation Requirements of Induced Murine Systemic Autoimmune Disease
J. Immunol., November 1, 2004; 173(9): 5880 - 5887.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Attanavanich and J. F. Kearney
Marginal Zone, but Not Follicular B Cells, Are Potent Activators of Naive CD4 T Cells
J. Immunol., January 15, 2004; 172(2): 803 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nierkens, P. van Helden, M. Bol, R. Bleumink, P. van Kooten, S. Ramdien-Murli, L. Boon, and R. Pieters
Selective Requirement for CD40-CD154 in Drug-Induced Type 1 Versus Type 2 Responses to Trinitrophenyl-Ovalbumin
J. Immunol., April 15, 2002; 168(8): 3747 - 3754.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S.-H. IM, D. BARCHAN, P. K. MAITI, L. RAVEH, M. C. SOUROUJON, and S. FUCHS
Suppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18
FASEB J, October 1, 2001; 15(12): 2140 - 2148.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Skapenko, P. E. Lipsky, H.-G. Kraetsch, J. R. Kalden, and H. Schulze-Koops
Antigen-Independent Th2 Cell Differentiation by Stimulation of CD28: Regulation Via IL-4 Gene Expression and Mitogen-Activated Protein Kinase Activation
J. Immunol., April 1, 2001; 166(7): 4283 - 4292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Lindgren, K. Axcrona, and T. Leanderson
Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2
J. Immunol., April 1, 2001; 166(7): 4578 - 4585.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Weller, A. Faili, C. Garcia, M. C. Braun, F. Le Deist, G. de Saint Basile, O. Hermine, A. Fischer, C.-A. Reynaud, and J.-C. Weill
CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans
PNAS, January 30, 2001; 98(3): 1166 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhan, A. J. Corbett, J. L. Brady, R. M. Sutherland, and A. M. Lew
CD4 Help-Independent Induction of Cytotoxic CD8 Cells to Allogeneic P815 Tumor Cells Is Absolutely Dependent on Costimulation
J. Immunol., October 1, 2000; 165(7): 3612 - 3619.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.